Published in Curr Opin Urol on March 01, 2012
Fluorescence imaging in surgery. IEEE Rev Biomed Eng (2013) 1.14
Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg (2013) 1.14
Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging (2013) 1.09
Intraoperative optical imaging and tissue interrogation during urologic surgery. Curr Opin Urol (2014) 0.95
Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases. ACS Nano (2013) 0.88
Fluorescein derivatives in intravital fluorescence imaging. Cells (2013) 0.83
Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1. J Am Chem Soc (2012) 0.83
A novel method for intraoperative sentinel lymph node detection in prostate cancer patients using superparamagnetic iron oxide nanoparticles and a handheld magnetometer: the initial clinical experience. Ann Surg Oncol (2014) 0.83
Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol (2014) 0.82
Advances in Robotic-Assisted Radical Prostatectomy over Time. Prostate Cancer (2013) 0.76
Beyond penile cancer, is there a role for sentinel node biopsy in urological malignancies? Clin Transl Imaging (2016) 0.75
Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev (2016) 0.75
Comment on Heuveling et al.: Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging (2012) 0.75
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood (2007) 3.67
Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. Int J Urol (2012) 2.76
Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol (2011) 2.63
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci U S A (2007) 2.39
Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01
Urine markers for bladder cancer surveillance: a systematic review. Eur Urol (2005) 1.90
Timing of curative treatment for prostate cancer: a systematic review. Eur Urol (2013) 1.63
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study. BJU Int (2009) 1.56
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection. Eur Urol (2010) 1.55
A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol (2006) 1.54
Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med (2012) 1.53
Prostate-sparing cystectomy: long-term oncological results. BJU Int (2009) 1.51
Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol (2007) 1.40
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol (2011) 1.25
Replication-selective oncolytic viruses in the treatment of cancer. Cancer Gene Ther (2005) 1.24
Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label. Bioconjug Chem (2010) 1.20
A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. Nanotechnology (2010) 1.18
Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model. J Biomed Opt (2011) 1.16
Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging (2012) 1.15
Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci (2012) 1.14
Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging (2013) 1.09
Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057. Eur Urol (2012) 1.09
In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology (2010) 1.03
Profiling proteasome activity in tissue with fluorescent probes. Mol Pharm (2007) 1.01
Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide. Bioconjug Chem (2011) 0.99
Imaging agents for the chemokine receptor 4 (CXCR4). Chem Soc Rev (2012) 0.98
Light interactions with gold nanorods and cells: implications for photothermal nanotherapeutics. Nano Lett (2011) 0.95
Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy (2009) 0.95
[Pregnancy following sexuality-preserving cystectomy for bladder carcinoma]. Ned Tijdschr Geneeskd (2011) 0.95
Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol (2012) 0.95
Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study. BJU Int (2011) 0.93
Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol (2005) 0.92
Selective self-organization of guest molecules in self-assembled molecular boxes. J Am Chem Soc (2005) 0.92
Image navigation as a means to expand the boundaries of fluorescence-guided surgery. Phys Med Biol (2012) 0.91
Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med (2009) 0.90
Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med (2012) 0.90
Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. Mol Pharm (2011) 0.90
Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases. Clin Cancer Res (2013) 0.89
Sentinel lymph node biopsy for prostate cancer: a hybrid approach. J Nucl Med (2013) 0.89
(Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre- and intraoperative imaging during sentinel lymph node resection. Nanotechnology (2010) 0.89
Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials (2011) 0.88
Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression. Chembiochem (2011) 0.88
Paraaortic sentinel lymph nodes: toward optimal detection and intraoperative localization using SPECT/CT and intraoperative real-time imaging. J Nucl Med (2010) 0.87
Dual-emissive quantum dots for multispectral intraoperative fluorescence imaging. Biomaterials (2010) 0.86
Quality of life in patients with low-risk prostate cancer. A comparative retrospective study: brachytherapy versus robot-assisted laparoscopic prostatectomy versus active surveillance. J Endourol (2013) 0.84
Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. Appl Radiat Isot (2010) 0.84
Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int (2008) 0.84
Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC. Transl Oncol (2011) 0.84
Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin. Chembiochem (2012) 0.83
Phosphorescence imaging of living cells with amino acid-functionalized tris(2-phenylpyridine)iridium(III) complexes. Inorg Chem (2012) 0.83
Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance. Int J Gynecol Cancer (2015) 0.82
Development of a Hybrid Tracer for SPECT and Optical Imaging of Bacterial Infections. Bioconjug Chem (2015) 0.82
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone. BJU Int (2014) 0.81
Tumor bracketing and safety margin estimation using multimodal marker seeds: a proof of concept. J Biomed Opt (2010) 0.81
Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS. PLoS One (2013) 0.80
Self-assembled ionophores from isoguanosine: diffusion NMR spectroscopy clarifies cation's and anion's influence on supramolecular structure. Chemistry (2007) 0.80
A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity. Nucl Med Commun (2016) 0.79
First Robotic SPECT for Minimally Invasive Sentinel Lymph Node Mapping. IEEE Trans Med Imaging (2015) 0.79
CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model. Clin Exp Metastasis (2014) 0.79
Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging. Lab Anim (2009) 0.78
Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging (2015) 0.78
Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose? Scand J Urol (2014) 0.78
An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors. Radiother Oncol (2007) 0.78
Dendritic ruthenium(II)-based dyes tuneable for diagnostic or therapeutic applications. Chemistry (2010) 0.77
Minimizing the number of implantation needles for prostate (125)I brachytherapy: an investigation of possibilities and implications. Brachytherapy (2010) 0.77
The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate. Radiother Oncol (2007) 0.77
An activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime. Chem Commun (Camb) (2014) 0.77
First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging (2015) 0.76
Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping? Eur J Nucl Med Mol Imaging (2015) 0.76
Lymphatic drainage from the treated versus untreated prostate: feasibility of sentinel node biopsy in recurrent cancer. Eur J Nucl Med Mol Imaging (2010) 0.76
Editorial comment on: A randomized phase 1 study of testosterone replacement for patients with low-risk castration-resistant prostate cancer. Eur Urol (2009) 0.75
Chemical castration and survival in low-risk prostate cancer. Eur Urol (2009) 0.75
Foreseeing cancer metastases. Eur Urol (2006) 0.75
Comment on Heuveling et al.: Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging (2012) 0.75
Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur Urol (2008) 0.75
Cytoskeleton fragments unveiling bladder cancer. Eur Urol (2007) 0.75
Editorial comment on: marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol (2008) 0.75
Editorial comment on: Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer. Eur Urol (2008) 0.75
Prepubic sentinel node location in penile carcinoma. Clin Nucl Med (2005) 0.75
Enhanced luminescence of Ag nanoclusters via surface modification. Nanotechnology (2013) 0.75
Erratum to: First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging (2015) 0.75
Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal Function. Urol Int (2017) 0.75
Size-Sorting and Pattern Formation of Nanoparticle-Loaded Micellar Superstructures in Biconcave Thin Films. ACS Nano (2017) 0.75
Photocontrolled release and uptake of a porphyrin guest by dithienylethene-tethered beta-cyclodextrin host dimers. Chemistry (2004) 0.75
Regulatory strategies in the complexation and release of a noncovalent guest trimer by a self-assembled molecular cage. Angew Chem Int Ed Engl (2003) 0.75
Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort. Eur J Cancer (2012) 0.75